机译:选择性E-前列腺素受体激动剂对血管加压素2的非加压素靶向作用可减轻肾原性尿崩症
Department of Biomedicine, Water and Salt Research Center, Aarhus University, DK-8000 Aarhus C, Denmark;
Department of Biomedicine, Water and Salt Research Center, Aarhus University, DK-8000 Aarhus C, Denmark;
Department of Biomedicine, Water and Salt Research Center, Aarhus University, DK-8000 Aarhus C, Denmark;
Department of Biomedicine, Water and Salt Research Center, Aarhus University, DK-8000 Aarhus C, Denmark;
Department of Biomedicine, Water and Salt Research Center, Aarhus University, DK-8000 Aarhus C, Denmark;
water balance; cell signaling; autocoid; lipid mediators; drug development/discovery;
机译:与加压素V2受体和水通道蛋白2突变相关的肾性尿崩症
机译:肾外糖尿病患者与血管加压素V2受体的突变相关,Aquaporin-2相关
机译:Aquaporin-2中新的常染色体隐性突变通过不足的靶向性导致肾原性尿崩症,在非洲爪蟾卵母细胞中显示正常表达。
机译:通过在多种代谢受体中起作用的合理设计肽激动剂治疗糖尿病和肥胖症
机译:烟碱乙酰胆碱受体的结构功能研究使用选择性激动剂和正变构调节剂。
机译:选择性E-前列腺素受体激动剂对血管加压素2的非加压素靶向作用可减轻肾原性尿崩症
机译:选择性E-前列腺素受体激动剂对血管加压素2的非加压素靶向作用可减轻肾原性尿崩症